Also, in a phase ii study of mct with etoposide and cyclophosphamide in combination with daily thalidomide and celecoxib for recurrent malignant gliomas in adults, the serum and urine levels of vegf, bfgf, endostatin, and tsp-1 were evaluated. This evidence concerns the gene COL18A1 and malignant glioma.